Secondary Glaucoma clinical trials at UCSF
1 in progress, 1 open to new patients
open to eligible people ages 18–85
This study will determine the effectiveness of Mitomycin-C use in the glaucoma surgery Ahmed valve implantation. Approximately 100 patients will be enrolled, with half receiving the Mitomycin-C treatment and the other half receiving placebo treatment.
San Francisco, California and other locations